The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
At one dose, the vaccine was found to be 75.2% effective. Back in 2022, when initial supplies were constrained, the FDA issued an emergency use authorization (EUA) allowing intradermal ...
Mpox, formally known as Monkeypox, cases are on the rise ... meaning they either never received a vaccine, or they only got one dose," Dr. Jenni McQuiston, deputy director of the CDC's high ...
In a society where facts are distorted and falsehoods proliferate, individuals are robbed of the ability to make sound ...
This was used as a dose-saving strategy as supplies were initially limited. The vaccine has been shown to be efficacious in studies using real-world data from the 2022 and onward outbreak among ...
Bavarian Nordic’s Jynneos, the only FDA-approved vaccine for mpox, recently made headway into the US commercial market.
Vaccine protection against mpox fades quickly in the human immune system, even in people who've received the full two-dose regimen, a new real-world study shows. Antibody levels fell to low or ...
Labcorp (NYSE:LH) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted emergency use authorization for its Mpox PCR Test Home Collection Kit, which can be used to detect ...
The 1.5 mg and 4.5 mg doses of Trulicity, another diabetes drug by Lilly, will also be available in limited amounts through April due to increased demand, according to the FDA's website.
The Food and Drug Administration ... (MenABCWY) vaccine candidate. The application is supported by data from a phase 3 trial (ClinicalTrials.gov Identifier: NCT04502693) in which study participants ...
With a final decision expected next February, MenABCWY combines the protective elements of GSK’s existing vaccines to target the five primary serogroups of Neisseria meningitidis. GSK announced that ...